Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Entrada Therapeutics (TRDA) Tax Provisions: 2023-2024

Historic Tax Provisions for Entrada Therapeutics (TRDA) over the last 2 years, with Dec 2024 value amounting to $900,000.

  • Entrada Therapeutics' Tax Provisions rose 136.84% to $700,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year decrease of 113.18%. This contributed to the annual value of $900,000 for FY2024, which is 95.20% down from last year.
  • As of FY2024, Entrada Therapeutics' Tax Provisions stood at $900,000, which was down 95.20% from $18.7 million recorded in FY2023.
  • Entrada Therapeutics' 5-year Tax Provisions high stood at $18.7 million for FY2023, and its period low was $900,000 during FY2024.
  • Moreover, its 2-year median value for Tax Provisions was $9.8 million (2023), whereas its average is $9.8 million.
  • Data for Entrada Therapeutics' Tax Provisions shows a maximum YoY plummeted of 95.20% (in 2024) over the last 5 years.
  • Over the past 2 years, Entrada Therapeutics' Tax Provisions (Yearly) stood at $18.7 million in 2023, then plummeted by 95.20% to $900,000 in 2024.